Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral Cavity75 moreThis phase I trial is studying the side effects and best dose of alvespimycin hydrochloride in treating patients with metastatic or unresectable solid tumors. Drugs used in chemotherapy, such as alvespimycin hydrochloride, work in different ways to stop tumor cells from dividing so they stop growing or die.
Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer...
Colorectal CancerRATIONALE: Less invasive types of surgery may help reduce the number of side effects and improve recovery. It is not yet known which type of surgery is more effective for colon cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of laparoscopic-assisted colectomy with open colectomy in treating patients who have colon cancer.
Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer
MalnutritionCancer of Colon2 moreAt present, the families of cancer patients are lack knowledge and experience of nutritional care after discharge. As a result, cancer patients often suffer from low nutritional status after being discharged from the hospital.
Prehabilitation of Frail Surgical Cancer Patients Using Remote Ischemic Preconditioning
Colon CancerFragility2 moreThis project will examine the efficacy of a simple, cost-effective, non-invasive intervention, called remote ischemic preconditioning (RIPC), to reduce frailty in pre-surgical, frail, elderly patients with colon cancer. The investigators hypothesize that RIPC will reduce frailty in the pre-surgical period (as assessed by distance walked during the 6-minute walk test), improve functional capacity 4-weeks postoperatively, and reduce intraoperative blood pressure variability. If successful, future studies will examine the efficacy of RIPC to improve surgical outcomes in frail cancer patients.
A Study of ASN007 in Patients With Advanced Solid Tumors
CancerMalignancy17 moreThe study is divided into two parts. The first part of the study will test various doses of ASN007 to find out the highest safe dose to test in five specific groups. The second part of the study will test how well ASN007 can control cancer.
Impact of Adjuvant Chemotherapy in Patients With Colon Cancer
Colon CancerAdjuvant ChemotherapyThe present study aims to investigate the impact of adjuvant chemotherapy with 5-FU isolated and associated with oxaliplatin in cardiac autonomic control and endothelium-dependent vascular function in patients undergoing colectomy for stages II and III colon cancer. Will be performed evaluation of cardiac and vascular function, autonomic control, functional capacity and blood evaluations.
The Effects of Mechnikov Probiotics on Symptom and Surgical Outcome
Sigmoid Colon CancerThe purpose of this clinical trial study was to evaluate the prevalence of colon cancer among the symptom (s) of anterior resection syndrome that may occur after surgery in patients for efficacy and safety in Metchnik probiotic ingestion.
Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing...
Colonic NeoplasmsDiverticulosis1 moreThis study analyses interest of iv nefopam in combination with paracetamol after major abdominal surgery because the effect of morphine-sparing is discussed when combined these agents.
Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Intravenous Bevacizumab-800CW...
Colorectal NeoplasmsColon Neoplasm2 moreThis prospective study aims to assess the safety and feasibility of lymph node identification using bevacizumab-800CW in patients with cT1-3N0-2 tumours, using intravenous administration.
Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW....
Colonic NeoplasmsSentinel Lymph Node2 moreThis prospective study aims to assess the safety and feasibility of lymph node identification using bevacizumab-800CW in patients with cT1-3N0-2 tumours, using peritumoral submucosal injections